Patents Assigned to Dignity Health
  • Patent number: 8482280
    Abstract: A system and method include a computer readable storage medium having stored thereon a computer program comprising instructions which when executed by a computer cause the computer to apply a first plurality of radio frequency (RF) pulses during a first repetition time (TR) interval of a magnetic resonance (MR) pulse sequence. The instructions also cause the computer to apply a first plurality of gradient pulses and acquire the MR data during application of each gradient pulse of the first plurality of gradient pulses between an adjacent pair of RF pulses of the first plurality of RF pulses. Each gradient pulse of the first plurality of gradient pulses is configured to allow acquisition of MR data for a respective first bladelet passing through a center of k-space, wherein the first bladelets are non-parallel with each other. The instructions also cause the computer to reconstruct the acquired MR data into an image.
    Type: Grant
    Filed: January 25, 2010
    Date of Patent: July 9, 2013
    Assignee: Dignity Health
    Inventors: Donglai Huo, James Grant Pipe
  • Publication number: 20130147394
    Abstract: A method and apparatus are provided for processing light from a light source. The method includes the steps of measuring a predetermined set of characteristics of the light source and detecting flicker when the predetermined set of characteristics exceed a corresponding flicker fusion threshold value.
    Type: Application
    Filed: January 10, 2013
    Publication date: June 13, 2013
    Applicant: DIGNITY HEALTH
    Inventor: Stephen L. Macknik
  • Publication number: 20130150357
    Abstract: The invention provides hydroxybupropion analogues capable of inhibiting the reuptake of one or more monoamines and/or acting as antagonists at nicotinic acetylcholine receptors. The compounds may selectively bind to one or more monoamine transporters, including those for dopamine, norepinephrine, and serotonin and/or may selectively bind to one or more nicotinic acetylcholine receptor subtypes. Such compounds may be used to treat conditions that are responsive to modification of monoamine levels and/or antagonism of nicotinic acetylcholine receptors, including drug dependency, depression, and obesity.
    Type: Application
    Filed: November 19, 2012
    Publication date: June 13, 2013
    Applicants: Research Triangle Institute, Virginia Commonwealth University, Dignity Health d/b/a St. Joseph's Hospital and Medical Center and Barrow Neurological Institute
    Inventors: Research Triangle Institute, Digital Health d/b/a St. Joseph's Hospital and Med, Virginia Commonwealth University
  • Publication number: 20130045987
    Abstract: Tetrahydroberberine (THB), isolated from the Chinese herb “Corydalis ambigua”, exhibits a variety of pharmacological effects, although mechanisms of action are unclear or entirely unknown. Described herein are novel methods of using tetrahydroberberine (THB), THB analogs or derivatives, tetrahydroprotoberberines (THPB). Tetrahydroberberine (THB) and analogs such as l-stepholidine (l-SPD) potently block functional KATP channels natively expressed on midbrain dopamine neurons. Further, THB also blocks pancreatic ?-cell KATP channels, and can be developed to a novel drugs for treating disease and/or conditions such as diabetes and Parkinson's disease.
    Type: Application
    Filed: May 2, 2011
    Publication date: February 21, 2013
    Applicant: DIGNITY HEALTH
    Inventor: Jie Wu
  • Patent number: 8373106
    Abstract: A method and apparatus are provided for processing light from a light source. The method includes the steps of measuring a predetermined set of characteristics of the light source and detecting flicker when the predetermined set of characteristics exceed a corresponding flicker fusion threshold value.
    Type: Grant
    Filed: October 18, 2007
    Date of Patent: February 12, 2013
    Assignee: Dignity Health
    Inventors: Stephen L. Macknik, Susana Martinez-Conde
  • Publication number: 20130023505
    Abstract: The invention relates to methods and pharmaceutical compositions for inhibiting or preventing preterm birth, inhibiting or delaying cervical ripening, inhibiting myometrial contractility and treating or inhibiting uterine contractility disorders. The methods comprise administering an effective amount of a composition comprising steroid hormones such as soluble progesterone.
    Type: Application
    Filed: September 6, 2012
    Publication date: January 24, 2013
    Applicant: DIGNITY HEALTH
    Inventors: Robert Garfield, Shao-Qing Shi, Leili Shi
  • Patent number: 8348428
    Abstract: A method and apparatus are provided for characterizing square wave jerks in the eye movements of a person, which may provide a powerful tool in the differential diagnosis of oculomotor and neurological disease. The method includes the steps of a) providing a sequence of saccades, b) identifying pairs of consecutive saccades of the sequence, c) determining whether each saccade of each identified pair is opposite the direction of the other saccade and, if not, then discarding the pair, d) determining whether a magnitude of each saccade of each identified pair is comparable and, if not, then discarding the pair, e) determining whether the pair of saccades of each identified pair are temporally related by a predetermined time period and, if not, then discarding the pair and f) collecting any remaining pairs of saccades as square wave jerks.
    Type: Grant
    Filed: October 31, 2008
    Date of Patent: January 8, 2013
    Assignee: Dignity Health
    Inventors: Susana Martinez-Conde, Stephen L. Macknik, Xoana Troncoso, Jorge Otero-Millan
  • Publication number: 20120252856
    Abstract: The present invention relates to methods of dividing cancer into subgroups based upon Akt pathway gene expression. In one embodiment, the present invention provides a method of diagnosing glioblastoma multiforme (GBM) subtype in an individual by determining the presence of an abnormal expression of an Akt pathway gene cluster and diagnosing the cancer subtype in the individual.
    Type: Application
    Filed: December 10, 2010
    Publication date: October 4, 2012
    Applicant: Dignity Health
    Inventors: Anna Joy, Burt G. Feuerstein, Ivan Smimov
  • Patent number: 8155755
    Abstract: A pair of sheets defining a disposable sheath for covering the electrical leads in a monitoring system used for monitoring patient vital signs and secured together along edges and along spaced seams to define a plurality of longitudinally extending compartments. A plurality of tear lines extend along the spaced seams from the second end to a distance spaced from the first end for laterally separating the compartments into separate arms, and fingers, whereby electrical leads may be bundled together in the open distance at the first end and inserted into the arms and fingers. A seal seals the sheets about the electrical leads at the respective ends.
    Type: Grant
    Filed: August 29, 2005
    Date of Patent: April 10, 2012
    Assignee: Dignity Health
    Inventors: Dawn Flynn, Faith OverStreet, Craig Orsini